Liu, Kevin S H <br/><br/>
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.  [electronic resource] 

 -  Gut  Sep 2014 
 - 1410-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2013-306120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amoxicillin--therapeutic use<br/>Antacids--therapeutic use<br/>Anti-Bacterial Agents--therapeutic use<br/>Anti-Ulcer Agents--therapeutic use<br/>Asian People<br/>Breath Tests<br/>China<br/>Clarithromycin--therapeutic use<br/>Cross-Over Studies<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Esomeprazole--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Helicobacter Infections--diagnosis<br/>Helicobacter pylori<br/>Humans<br/>Intention to Treat Analysis<br/>Male<br/>Metronidazole--therapeutic use<br/>Middle Aged<br/>Organometallic Compounds--therapeutic use<br/>Prospective Studies<br/>Tetracycline--therapeutic use<br/>Treatment Outcome